Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • KERYX BIOPHARMACEUTICALS INC Financial Overview

  • Income Statement: KERX

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 1.28 M 1.05 M 234,000.00 18.24%
    Gross Profit 1.14 M 750,000.00 395,000.00 34.50%
    Net Income Before Extra Items/Preferred Div -52.88 M -90.06 M 37.18 M -70.31%
    Operating Income -38.79 M -93.98 M 55.19 M -142.30%
  • Cash Flow: KERX

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 222,000.00 3,000.00 219,000.00 98.65%
    Net Cash Flow - Investing -32.59 M -27.87 M -4.72 M 14.48%
    Net Cash Flow/Operating Activities -38.73 M -57.54 M 18.81 M -48.57%
  • Balance Sheet: KERX

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 26.63 M 81.06 M -54.43 M -204.35%
    Total Liabilities 28.12 M 36.64 M -8.52 M -30.28%
    Shareholders Equity -1.49 M 44.42 M -45.91 M 3,083.34%
  • Key Ratios / Statistics: KERX

    • Valuation

      Price/Earnings (TTM) -0.19
      Price/Sales (TTM) 7.71
      Price/Book (MRQ) 2.86
      Price/Cash Flow (TTM) 9.10
    • Profitability

      Gross Margin 89.24
      Operating Margin -3,023.15
      Profit Margin -4,121.67
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 2.31
      Current Ratio (MRQ) 2.72
      Long Term Debt-to-Equity (MRQ) 0.00
    • Management Effectiveness

      Return on Equity (TTM) -239.37
      Return on Assets (TTM) -98.21
      Return on Investments (TTM) -246.34